AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
TUMOR RETENTION OF RE-186-MAG3, IN-111-DTPA AND I-125 LABELED MONOCLONAL-ANTIBODY G250 IN NUDE-MICE WITH RENAL-CELL CARCINOMA XENOGRAFTS
Authors: STEFFENS MG KRANENBORG MHGC BOERMAN OC ZEGWAARTHAGEMEIER NEM DEBRUYNE FMJ CORSTENS FHM OOSTERWIJK E
Citation: Mg. Steffens et al., TUMOR RETENTION OF RE-186-MAG3, IN-111-DTPA AND I-125 LABELED MONOCLONAL-ANTIBODY G250 IN NUDE-MICE WITH RENAL-CELL CARCINOMA XENOGRAFTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 133-139
PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/
Authors: DIVGI CR BANDER NH SCOTT AM ODONOGHUE JA SGOUROS G WELT S FINN RD MORRISSEY F CAPITELLI P WILLIAMS JM DELAND D NAKHRE A OOSTERWIJK E GULEC S GRAHAM MC LARSON SM OLD LJ
Citation: Cr. Divgi et al., PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/, Clinical cancer research, 4(11), 1998, pp. 2729-2739
EXPRESSION OF CADHERIN-6 AS A NOVEL DIAGNOSTIC-TOOL TO PREDICT PROGNOSIS OF PATIENTS WITH E-CADHERIN-ABSENT RENAL-CELL CARCINOMA
Authors: SHIMAZUI T OOSTERWIJK E AKAZA H BRINGUIER PP RUIJTER E VANBERKEL H WAKKA JO VANBOKHOVEN A DEBRUYNE FMJ SCHALKEN JA
Citation: T. Shimazui et al., EXPRESSION OF CADHERIN-6 AS A NOVEL DIAGNOSTIC-TOOL TO PREDICT PROGNOSIS OF PATIENTS WITH E-CADHERIN-ABSENT RENAL-CELL CARCINOMA, Clinical cancer research, 4(10), 1998, pp. 2419-2424
2-STEP TARGETING OF RCC TUMORS IN MICE - IMPROVED TUMOR UPTAKE AND RETENTION WITH A BIVALENT CHELATE
Authors: KRANENBORG MHGC BOERMAN OC GRIFFITHS GL OOSTERWIJK JC DEWEIJERT MCA MCBRIDE B HANSEN HJ OOSTERWIJK E CORSTENS FHM
Citation: Mhgc. Kranenborg et al., 2-STEP TARGETING OF RCC TUMORS IN MICE - IMPROVED TUMOR UPTAKE AND RETENTION WITH A BIVALENT CHELATE, The Journal of nuclear medicine, 39(5), 1998, pp. 301-301
IMMUNOSCINTIGRAPHY AND BIODISTRIBUTION OF 3 TC-99M-G250 MAB PREPARATIONS IN NUDE-MICE WITH S.C. RCC TUMORS
Authors: STEFFENS MG BOERMAN OC OOSTERWIJK E KRANENBORG MHGC DEBRUYNE FMJ CORSTENS FHM
Citation: Mg. Steffens et al., IMMUNOSCINTIGRAPHY AND BIODISTRIBUTION OF 3 TC-99M-G250 MAB PREPARATIONS IN NUDE-MICE WITH S.C. RCC TUMORS, The Journal of nuclear medicine, 39(5), 1998, pp. 1073-1073
CLINICAL-EVALUATION OF THE DISTRIBUTION OF 2 DIFFERENT RADIOLABELED INJECTIONS OF CHIMERIC MONOCLONAL-ANTIBODY G250 IN PATIENTS WITH PRIMARY RCC
Authors: STEFFENS MG BOERMAN OC OOSTERWIJK E OYEN WJG WITJES JA OOSTERHOF GON DEBRUYNE FMJ CORSTENS FHM
Citation: Mg. Steffens et al., CLINICAL-EVALUATION OF THE DISTRIBUTION OF 2 DIFFERENT RADIOLABELED INJECTIONS OF CHIMERIC MONOCLONAL-ANTIBODY G250 IN PATIENTS WITH PRIMARY RCC, The Journal of nuclear medicine, 39(5), 1998, pp. 1086-1086
PHASE I II RADIOIMMUNOTHERAPY WITH I-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY CG250 IN PATIENTS WITH METASTASIZED RENAL-CELL CARCINOMA/
Authors: STEFFENS MG BOERMAN OC OOSTERWIJK E OYEN WJG DEMULDER PHM WITJES JA OOSTERHOF GON DEBRUYNE FMJ CORSTENS FHM
Citation: Mg. Steffens et al., PHASE I II RADIOIMMUNOTHERAPY WITH I-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY CG250 IN PATIENTS WITH METASTASIZED RENAL-CELL CARCINOMA/, The Journal of nuclear medicine, 39(5), 1998, pp. 1089-1089
DETECTION OF DNA AMPLIFICATION IN HUMAN RENAL-CELL CARCINOMA CELL-LINES USING RESTRICTION LANDMARK GENOMIC SCANNING
Authors: CHO M KONISHI N KITAHORI Y HIASA Y NAKAGAWA YI UEMURA H HIRAO Y OOSTERWIJK E
Citation: M. Cho et al., DETECTION OF DNA AMPLIFICATION IN HUMAN RENAL-CELL CARCINOMA CELL-LINES USING RESTRICTION LANDMARK GENOMIC SCANNING, Cellular and molecular biology, 44(6), 1998, pp. 913-918
RADIOIMMUNOTHERAPY WITH I-131 CG250 MONOCLONAL-ANTIBODY IN PATIENTS WITH METASTASIZED RCC, A PHASE I II STUDY/
Authors: STEFFENS MG BOERMAN OC OYEN WJG DEMULDER PHM WITJES JA OOSTERHOF GON CORSTENS FHM DEBRUYNE FMJ OOSTERWIJK E
Citation: Mg. Steffens et al., RADIOIMMUNOTHERAPY WITH I-131 CG250 MONOCLONAL-ANTIBODY IN PATIENTS WITH METASTASIZED RCC, A PHASE I II STUDY/, The Journal of urology, 159(5), 1998, pp. 562-562
DECREASED CADHERIN-6 EXPRESSION IS ASSOCIATED WITH POOR-PROGNOSIS OF THE PATIENTS WITH RENAL-CELL CARCINOMA
Authors: SHIMAZUI T AKAZA H OOSTERWIJK E DEBRUYNE FMJ SCHALKEN JA
Citation: T. Shimazui et al., DECREASED CADHERIN-6 EXPRESSION IS ASSOCIATED WITH POOR-PROGNOSIS OF THE PATIENTS WITH RENAL-CELL CARCINOMA, The Journal of urology, 159(5), 1998, pp. 571-571
MN AS A POTENTIAL TARGET IN RENAL-CELL CARCINOMA
Authors: NAKAGAWA Y UEMURA H HIRAO Y OKAJIMA E YOSHIKAWA K SAGA S OOSTERWIJK E
Citation: Y. Nakagawa et al., MN AS A POTENTIAL TARGET IN RENAL-CELL CARCINOMA, The Journal of urology, 159(5), 1998, pp. 720-720
MN TARGET IMMUNOTHERAPY FOR RENAL-CELL CARCINOMA
Authors: UEMURA H NAKAGAWA Y OKAJIMA E HIRAO Y YOSHIKAWA K SAGA S OOSTERWIJK E
Citation: H. Uemura et al., MN TARGET IMMUNOTHERAPY FOR RENAL-CELL CARCINOMA, The Journal of urology, 159(5), 1998, pp. 724-724
IMMUNOHISTOCHEMICAL ANALYSIS OF INTRATUMORAL HETEROGENEITY OF [I-131]CG250 ANTIBODY UPTAKE IN PRIMARY RENAL-CELL CARCINOMAS
Authors: STEFFENS MG OOSTERWIJK E ZEGWAARTHAGEMEIER NE VANTHOF MA DEBRUYNE FM CORSTENS FH BOERMAN OC
Citation: Mg. Steffens et al., IMMUNOHISTOCHEMICAL ANALYSIS OF INTRATUMORAL HETEROGENEITY OF [I-131]CG250 ANTIBODY UPTAKE IN PRIMARY RENAL-CELL CARCINOMAS, British Journal of Cancer, 78(9), 1998, pp. 1208-1213
TARGETING OF RENAL-CELL CARCINOMA WITH IODINE-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY G250
Authors: STEFFENS MG BOERMAN OC OOSTERWIJKWAKKA JC OOSTERHOF GON WITJES JA KOENDERS EB OYEN WJG BUIJS WCAM DEBRUYNE FMJ CORSTENS FHM OOSTERWIJK E
Citation: Mg. Steffens et al., TARGETING OF RENAL-CELL CARCINOMA WITH IODINE-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY G250, Journal of clinical oncology, 15(4), 1997, pp. 1529-1537
RAPID IMAGING OF EXPERIMENTAL-INFECTION WITH TECHNETIUM-99M-DTPA AFTER ANTI-DTPA MONOCLONAL-ANTIBODY PRIMING
Authors: KRANENBORG MHGC OYEN WJG CORSTENS FHM OOSTERWIJK E VANDERMEER JWM BOERMAN OC
Citation: Mhgc. Kranenborg et al., RAPID IMAGING OF EXPERIMENTAL-INFECTION WITH TECHNETIUM-99M-DTPA AFTER ANTI-DTPA MONOCLONAL-ANTIBODY PRIMING, The Journal of nuclear medicine, 38(6), 1997, pp. 901-906
MULTISTEP TARGETING OF RENAL-CELL CARCINOMA WITH ANTI-RCC X ANTI-DTPABISPECIFIC MONOCLONAL-ANTIBODIES
Authors: KRANENBORG MHGC BOERMAN OC OOSTERWIJK JC DEWEIJERT MCA OOSTERWIJK E CORSTENS FHM
Citation: Mhgc. Kranenborg et al., MULTISTEP TARGETING OF RENAL-CELL CARCINOMA WITH ANTI-RCC X ANTI-DTPABISPECIFIC MONOCLONAL-ANTIBODIES, The Journal of nuclear medicine, 38(5), 1997, pp. 820-820
RED MARROW DOSIMETRY AFTER ADMINISTRATION OF I-131-LABELED CHIMERIC G250 MONOCLONAL-ANTIBODY (CG250) IN PATIENTS WITH RENAL-CELL CARCINOMA,BASED ON PLANAR GAMMA-CAMERA IMAGES
Authors: BUIJS WCAM STEFFENS MG BOERMAN O SIEGEL JA OOSTERWIJK E CORSTENS FHM
Citation: Wcam. Buijs et al., RED MARROW DOSIMETRY AFTER ADMINISTRATION OF I-131-LABELED CHIMERIC G250 MONOCLONAL-ANTIBODY (CG250) IN PATIENTS WITH RENAL-CELL CARCINOMA,BASED ON PLANAR GAMMA-CAMERA IMAGES, The Journal of nuclear medicine, 38(5), 1997, pp. 958-958
DECREASED EXPRESSION OF ALPHA-CATENIN IS ASSOCIATED WITH POOR-PROGNOSIS OF PATIENTS WITH LOCALIZED RENAL-CELL CARCINOMA
Authors: SHIMAZUI T BRINGUIER PP VANBERKEL H RUIJTER E AKAZA H DEBRUYNE FMJ OOSTERWIJK E SCHALKEN JA
Citation: T. Shimazui et al., DECREASED EXPRESSION OF ALPHA-CATENIN IS ASSOCIATED WITH POOR-PROGNOSIS OF PATIENTS WITH LOCALIZED RENAL-CELL CARCINOMA, International journal of cancer, 74(5), 1997, pp. 523-528
THE EFFECT OF ANTIBODY PROTEIN DOSE OF ANTIRENAL CELL-CARCINOMA MONOCLONAL-ANTIBODIES IN NUDE-MICE WITH RENAL-CELL CARCINOMA XENOGRAFTS
Authors: KRANENBORG MHGC BOERMAN OC DEWEIJERT MCA OOSTERWIJKWAKKA JC CORSTENS FHM OOSTERWIJK E
Citation: Mhgc. Kranenborg et al., THE EFFECT OF ANTIBODY PROTEIN DOSE OF ANTIRENAL CELL-CARCINOMA MONOCLONAL-ANTIBODIES IN NUDE-MICE WITH RENAL-CELL CARCINOMA XENOGRAFTS, Cancer, 80(12), 1997, pp. 2390-2397
ANTI-RENAL-CELL CARCINOMA CHIMERIC ANTIBODY G250 FACILITATES ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY WITH IN-VITRO AND IN-VIVO INTERLEUKIN-2-ACTIVATED EFFECTORS
Authors: SURFUS JE HANK JA OOSTERWIJK E WELT S LINDSTROM MJ ALBERTINI MR SCHILLER JH SONDEL PM
Citation: Je. Surfus et al., ANTI-RENAL-CELL CARCINOMA CHIMERIC ANTIBODY G250 FACILITATES ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY WITH IN-VITRO AND IN-VIVO INTERLEUKIN-2-ACTIVATED EFFECTORS, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 184-191
RADIOIMMUNOTARGETING WITH I-131-LABELED CHIMERIC G250 MONOCLONAL-ANTIBODY IN PATIENTS WITH RENAL-CELL CARCINOMA
Authors: STEFFENS MG BOERMAN OC OOSTERWIJK E OOSTERHOF GON WITJES JA OOSTERWIJKWAKKA JC KOENDERS E DEBRUYNE FMJ CORSTENS FHM
Citation: Mg. Steffens et al., RADIOIMMUNOTARGETING WITH I-131-LABELED CHIMERIC G250 MONOCLONAL-ANTIBODY IN PATIENTS WITH RENAL-CELL CARCINOMA, The Journal of nuclear medicine, 37(5), 1996, pp. 740-740
AMINOPEPTIDASE-A IS A CONSTITUENT OF ACTIVATED PERICYTES IN ANGIOGENESIS
Authors: SCHLINGEMANN RO OOSTERWIJK E WESSELING P RIETVELD FJR RUITER DJ
Citation: Ro. Schlingemann et al., AMINOPEPTIDASE-A IS A CONSTITUENT OF ACTIVATED PERICYTES IN ANGIOGENESIS, Journal of pathology, 179(4), 1996, pp. 436-442
COMPLEX CADHERIN EXPRESSION IN RENAL-CELL CARCINOMA
Authors: SHIMAZUI T GIROIDI LA BRINGUIER PP OOSTERWIJK E SCHALKEN JA
Citation: T. Shimazui et al., COMPLEX CADHERIN EXPRESSION IN RENAL-CELL CARCINOMA, Cancer research, 56(14), 1996, pp. 3234-3237
RADIOLABELED MONOCLONAL-ANTIBODY G250 IN RENAL-CELL CARCINOMA
Authors: OOSTERWIJK E DEBRUYNE FMJ
Citation: E. Oosterwijk et Fmj. Debruyne, RADIOLABELED MONOCLONAL-ANTIBODY G250 IN RENAL-CELL CARCINOMA, World journal of urology, 13(3), 1995, pp. 186-190
THE USE OF MONOCLONAL-ANTIBODY G250 IN THE THERAPY OF RENAL-CELL CARCINOMA
Authors: OOSTERWIJK E DEBRUYNE FMJ SCHALKEN JA
Citation: E. Oosterwijk et al., THE USE OF MONOCLONAL-ANTIBODY G250 IN THE THERAPY OF RENAL-CELL CARCINOMA, Seminars in oncology, 22(1), 1995, pp. 34-41
Risultati: 1-25 | 26-32